MSOs and consolidation

What is an MSO, and why does cannabis have them?

A multi-state operator is a holding company over a set of separate in-state cannabis businesses. It exists in that form because of one rule: marijuana cannot lawfully cross a state line, even between two legal states. Each state is a closed market with its own regulator, its own track-and-trace system, and its own licenses. A company that wants national scale has to build or buy a complete supply chain in every state it enters. The legal background is in interstate commerce and trigger laws.

That structure shapes everything about consolidation in this industry:

• Scale is state by state. Ten stores in one capped state are worth more to an operator than one store in each of ten states. Overhead, brand, and wholesale leverage only compound inside a state border.
• Costs are duplicated. An MSO in eight states runs eight grows, eight kitchens, and eight compliance programs. There is no national distribution center.
• Every acquisition is a licensing event. Each deal needs change of ownership approval from every affected state and often from cities too.
• Public MSOs list in Canada. Most trade on the Canadian Securities Exchange and on U.S. OTC markets, because major U.S. exchanges will not list companies with material federally unlawful activity.

Single-state operators with several licenses behave much like MSOs inside their home market. For a seller, a strong regional group is often a more likely buyer than a national name.

The 2025 to 2026 picture: consolidation by break-up

Consolidation in 2026 is less about big companies merging and more about weak balance sheets being taken apart and the pieces moving to stronger hands.

The cause is debt. The large MSOs borrowed heavily between 2020 and 2022, at high rates, to build capacity for markets that then saw falling prices. An October 2025 analysis by Blank Rome put about $6 billion of cannabis debt as maturing by the end of 2026, with roughly $3.4 billion owed by the five largest MSOs. It noted one large operator refinancing into a $325 million senior secured loan at 12.5%, and another selling licenses across eight states to satisfy lenders.

Ordinary companies in that position refinance with a bank or file chapter 11. Plant-touching cannabis companies can do neither. Banks and the SBA stay out, as covered in why SBA and banks are unavailable, and federal bankruptcy courts generally dismiss marijuana cases. What is left is asset sales, lender takeovers, state receiverships, and, for Canadian-listed parents, Canadian insolvency proceedings. See receiverships and the bankruptcy gap.

Three restructurings that show the pattern

Company	What happened	Date and source
AYR Wellness	Transferred its Florida, New Jersey, and Nevada operations, including more than 60 Florida dispensaries, to subsidiaries of a vehicle set up by its senior secured noteholders	Closed 2 June 2026, per the company’s release
The Cannabist Company	Entered proceedings under Canada’s Companies’ Creditors Arrangement Act with U.S. chapter 15 recognition, and sold its footprint state by state	Announced 24 March 2026
TerrAscend (Michigan only)	On the application of FG Agency Lending, agent for its term-loan lenders, and with the Michigan subsidiaries’ consent, the Oakland County Circuit Court appointed a receiver over its nine Michigan entities, which TerrAscend then deconsolidated. The roughly $210 million figure often quoted is TerrAscend’s total company-wide loan principal ($209.7 million at 30 June 2026), not a Michigan debt; the lenders agreed to forbear on the defaults the receivership caused	Order entered 6 May 2026, per the company’s 10-Q

The Cannabist sales are the most useful for owners because prices were disclosed. Its central Virginia medical business, with five stores, a sixth in development, and about 82,000 square feet of cultivation and production, sold for $130 million to an affiliate of a credit fund, with $117.5 million paid at closing. A go-shop period produced that bid after an earlier agreement with another MSO. Its Delaware assets went for $16.5 million in cash under the March 2026 agreement. By contrast, a five-state package of up to 25 dispensaries plus one cultivation and one production asset in Colorado, Illinois, Massachusetts, New Jersey, and West Virginia was priced at up to $35 million in July 2026: up to $18.75 million in cash at closing and up to $16.25 million in seller notes, with closings staged into 2027 and subject to regulatory approval and the insolvency proceedings. That works out to at most about $1.4 million per store.

The gap is the lesson. A coherent, vertically integrated position in a capped medical state drew a competitive cash bid. A scattered set of stores across mixed markets was priced in bulk at a fraction per unit. How scarcity drives that difference is covered in limited-license vs open-market states.

Note who bought Virginia: a credit fund affiliate, not an operator. Lenders and credit investors now own meaningful parts of the industry, through foreclosure or purchase. They are often temporary owners, which means many of these assets will come to market again.

The consolidators

A small group is buying. The most visible in public filings has been Vireo Growth. In December 2024 it announced four all-stock acquisitions of single-state operators in Missouri, Nevada, Utah, and Florida for about $397 million, priced at roughly 4.2x to 5.4x reference EBITDA. In July 2026 it agreed to acquire Planet 13 in a share exchange that remains subject to stockholder, exchange, and state cannabis approvals. It is also the buyer under the July 2026 agreement for the Cannabist five-state package.

Three features recur:

1. Buyers want platforms or fill-ins. Whole single-state operators with management in place, or stores that fill a gap where the buyer already has cultivation.
2. Little cash changes hands. Viridian Capital data reported by Forbes in January 2026 put cash at under 2% of disclosed deal consideration in 2025.
3. Much of the activity is private. The same report’s theme is that deals continue away from public announcements, among private operators, lenders, and family offices.

What can an MSO afford to pay?

An acquirer paying in shares cannot easily pay a higher multiple than the market gives its own stock. Viridian Capital reported in November 2025 that public MSOs with market caps above $100 million traded at a median 5.1x enterprise value to 2026 EBITDA. Vireo’s 2024 deals at 4.2x to 5.4x sit right at that line.

Illustrative arithmetic: an MSO trading at 5.0x buys a store group earning $2.0 million of EBITDA. At 4.0x it pays $8.0 million in shares, and the market values the added earnings at $10.0 million, so the deal adds value for its holders. At 6.5x it pays $13.0 million for something the market values at $10.0 million. The second deal only works if the buyer can show cost savings or wholesale margin that lift the acquired EBITDA. That is why MSO offers cluster near the buyer’s own multiple, and why the highest prices go to assets with obvious synergy in a state the buyer already serves.

Private-deal ranges by license type are in dispensary valuation multiples. How to weigh an MSO offer against a private one, including lock-ups and clawbacks, is covered in selling to an MSO vs a private buyer and selling for MSO stock.

What limits consolidation?

Several brakes keep cannabis from consolidating the way alcohol or pharmacy retail did.

Ownership caps. Many states limit what one owner can hold. Illinois will not approve a sale that takes any owner above 10 adult-use dispensing licenses. Maryland allows four dispensaries. Massachusetts raised its retail limit from three to six in 2026. The largest operators in a state are often at the cap, which hands the next acquisition to a mid-sized group. The full table is in ownership caps and residency rules by state.

Transfer locks. New, converted, and social equity licenses often cannot change control for years. See social equity license transfer restrictions.

Capital. With cash scarce and share prices low, buyers ration deals. Every share issued at a depressed price is expensive for existing holders.

Tax. Adult-use operators remain subject to section 280E, and many large operators carry substantial unpaid or disputed tax balances. The April 2026 order moved state-licensed medical marijuana to Schedule III, which helps medical-heavy operators going forward, but adult-use stays in Schedule I. Details are in 280E explained for buyers and sellers.

Exchange access. Trulieve began trading on the NYSE on 10 June 2026 only after separating its adult-use business. Others with material adult-use revenue remain on the CSE and OTC markets. Until that changes, acquisition currency stays weak.

No economies across borders. Because product cannot move between states, a national footprint produces fewer savings than it would in a normal industry. Several MSOs have concluded that depth in five good states beats presence in fifteen.

What consolidation means if you own an independent business

Know which side of the market your state is on. In states where MSOs are exiting, their stores and grows compete with yours for the same buyers. In states where they are filling in, you may be the target. A simple check: list the five largest license holders in your state, their license counts against the cap, and whether each has announced an exit, a restructuring, or an acquisition in the past 12 months.

Expect paper, and price it. Offers from public acquirers will lead with shares and notes. Compare offers on cash at close plus risk-adjusted deferred value, not the headline.

Check the buyer’s balance sheet. Several of the names that were buying in 2021 were selling under lender pressure by 2026. Before granting exclusivity, read the acquirer’s latest quarterly filing for debt maturities inside your expected approval period and any lock-up. A buyer that loses its financing after six months of regulatory review costs you a year.

Regional buyers matter more than they used to. With national operators capped, capital-constrained, or retreating, single-state groups and private investors are doing a large share of the smaller deals, often with more cash as a proportion of price.

Wholesale exposure. If you are a cultivator or manufacturer selling to MSO-owned stores, consolidation can shrink your shelf space as acquirers push house brands. Buyers of your business will ask how much revenue depends on accounts that could be internalized.

A broker will typically approach strategic and private buyers in the same confidential process, so the owner can compare real offers instead of guessing which group will pay more. If you want to talk through where your business sits, the intro call is free.

What consolidation means if you are a buyer

MSO retreats are deal flow. When a large operator leaves a state, it sells operating stores and facilities with trained staff, clean compliance systems, and audited numbers, sometimes at prices set by a lender’s deadline. Points to check:

• Why the seller is leaving. If the reason is state-level price compression, you inherit it. See how oversupply and price compression affect value.
• Stand-alone costs. A carved-out store has been using the parent’s purchasing, software, compliance staff, and brand. Rebuild the income statement without them and negotiate transition services.
• Leases. Many MSO sites sit under sale-leasebacks with above-market rent and parent guarantees. The landlord’s consent and the rent reset are part of the price.
• Process. Lender-driven and court-supervised sales move on fixed timetables with limited representations. The mechanics are in buying a license out of receivership.

Buyers thinking about assembling their own group should read multi-state platform building before copying a model that several large operators are now unwinding.

What to watch

Signal	Why it matters
Outcome of the federal rescheduling hearing for adult-use marijuana (no recommendation or final rule as of mid-September 2026)	Removing 280E for adult-use operators would raise after-tax cash flow and acquisition capacity. See rescheduling status.
SAFE Banking Act of 2026 (introduced June 2026, not enacted)	Cheaper debt would let buyers pay more cash.
Further exchange listings	Better acquisition currency for public buyers.
State cap changes	A raised cap, as in Massachusetts in 2026, reopens the largest in-state operators as buyers.
Resale of lender-owned portfolios	Credit funds that took over assets in 2026 are likely sellers in the next few years.

None of these has a reliable timetable. Owners who plan a sale around a federal event are making a bet, and should be able to carry the business if the event does not arrive. This guide is educational and is not legal, tax, or investment advice.